Raw materials for biological processes

BAY 11-7082 is a NF-κB inhibitor, inhibits TNFα-induced IκBα phosphorylation with IC50 of 10 μM. Also inhibiting components of the ubiquitin system.An anti-inflammatory agent and NFκB inhibitor

BAY 11-7082 is a NF-κB inhibitor, inhibits TNFα-induced IκBα phosphorylation with IC50 of 10 μM. Also inhibiting components of the ubiquitin system.An anti-inflammatory agent and NFκB inhibitor

BAY 11-7082 is a NF-κB inhibitor, inhibits TNFα-induced IκBα phosphorylation with IC50 of 10 μM. Also inhibiting components of the ubiquitin system.An anti-inflammatory agent and NFκB inhibitor

Bethanechol Chloride is a selective muscarinic receptor agonist without any effect on nicotinic receptors. Target: mAChR Bethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors without any effect on

Bethanechol Chloride is a selective muscarinic receptor agonist without any effect on nicotinic receptors. Target: mAChR Bethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors without any effect on

Bethanechol Chloride is a selective muscarinic receptor agonist without any effect on nicotinic receptors. Target: mAChR Bethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors without any effect on

Bethanechol Chloride is a selective muscarinic receptor agonist without any effect on nicotinic receptors. Target: mAChR Bethanechol is a parasympathomimetic choline carbamate that selectively stimulates muscarinic receptors without any effect on

Bezafibrate is the first clinically tested dual and pan-PPAR co-agonism.A peroxisome proliferator and hypolipidaemic agent.

Bezafibrate is the first clinically tested dual and pan-PPAR co-agonism.A peroxisome proliferator and hypolipidaemic agent.

Bezafibrate is the first clinically tested dual and pan-PPAR co-agonism.A peroxisome proliferator and hypolipidaemic agent.

Bezafibrate is the first clinically tested dual and pan-PPAR co-agonism.A peroxisome proliferator and hypolipidaemic agent.

Bezafibrate is the first clinically tested dual and pan-PPAR co-agonism.A peroxisome proliferator and hypolipidaemic agent.